Sublingual and oral immunotherapy

被引：10

作者：

Canonica, GW ^{[1
]}

Compalati, E ^{[1
]}

Fumagalli, F ^{[1
]}

Passalacqua, G ^{[1
]}

机构：

[1] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2004年 / 24卷 / 04期

关键词：

D O I：

10.1016/j.iac.2004.07.001

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Sublingual immunotherapy (SLIT) is a viable alternative to the subcutaneous route for the treatment of respiratory allergy, whereas the pure oral route has been abandoned because of its lack of efficacy. The main distinctive feature of SLIT is its optimal safety profile, which has been demonstrated in adults and children. The indications for SLIT are similar to those for the subcutaneous route. A long-lasting effect has been demonstrated for the sublingual route, but data are needed to determine the optimal dose and the preventive effect in asthma.

引用

收藏

页码：685 / +

页数：21

相关论文

共 127 条

[81] SAFETY AND EFFICACY OF ORAL IMMUNOTHERAPY WITH STANDARDIZED CAT EXTRACT [J].

OPPENHEIMER, J ;

ARESON, JG ;

NELSON, HS .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (01) :61-67

[82]

OSTERGAARD PA, 1986, ALLERGY, V41, P588

[83] Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study [J].

Pajno, GB ;

Morabito, L ;

Barberio, G ;

Parmiani, S .

ALLERGY, 2000, 55 (09) :842-849

[84] Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy:: a randomized controlled trial [J].

Pajno, GB ;

Passalacqua, G ;

Vita, D ;

Caminiti, L ;

Parmiani, S ;

Barberio, G .

ALLERGY, 2004, 59 (08) :883-887

[85] Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate [J].

Pajno, GB ;

Vita, D ;

Parmiani, S ;

Caminiti, L ;

La Grutta, S ;

Barberio, G .

CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (12) :1641-1647

[86] Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. [J].

Pajno, GB ;

Barberio, G ;

De Luca, F ;

Morabito, L ;

Parmiani, S .

CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (09) :1392-1397

[87] Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species:: A double-blind, placebo-controlled trial [J].

Passalacqua, G ;

Albano, M ;

Riccio, A ;

Fregonese, L ;

Puccinelli, P ;

Parmiani, S ;

Canonica, GW .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (05) :964-968

[88] Sublingual or injection immunotherapy: the final answer? [J].

Passalacqua, G ;

Canonica, GW .

ALLERGY, 2004, 59 (01) :37-38

[89] Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis [J].

Passalacqua, G ;

Albano, M ;

Fregonese, L ;

Riccio, A ;

Pronzato, C ;

Mela, GS ;

Canonica, GW .

LANCET, 1998, 351 (9103) :629-632

[90] Long-lasting clinical efficacy of allergen specific immunotherapy [J].

Passalacqua, G ;

Canonica, GW .

ALLERGY, 2002, 57 (04) :275-276

← 4 5 6 7 8 9 10 11 12 13 →